Literature DB >> 91570

Purification of the subunit Clq from the first component of equine complement.

T L McDonald, D Burger.   

Abstract

Initial separation and concentration of Clq from fresh, normal equine serum was accomplished by precipitation in 0.02 M acetate buffer, pH 5.5, at 4 degrees for 24 h. The re-dissolved precipitate was clarified by centrifugation at 80,000 g for 1 h and then dialysed against Tris-HCl buffer (0.05 M, pH 8.0) containing 10-3 M EDTA. The clarified dialysate remained biologically active at 5 degrees for at least 4 weeks. Biological activity of equine Clq was determined by assay of its ability to agglutinate sensitized sheep erythrocytes (EA). Following ammonium sulphate fractionation, Sepharose 4B gel filtration yielded three major peaks. Two protein bands were demonstrated on analysis of the second Sepharose peak by disc acrylamide electrophoresis, pH 8.3. Elution of the protein bands showed EA-agglutinating activity only in the band which migrated furthest toward the cathode. Equine Clq isolated by this method yielded an approximate forty-fold purification in specific activity. Some properties of equine Clq were characterized. Equine Clq was heat-labile, as shown by loss of its EA-agglutinating activity after heating 58 degrees for 15 min. Moreover, storage at 4 degrees and freeze-thaw cycles greatly reduced EA agglutination. Preliminary determination of the sedimentation coefficient indicated that it was comparable to that reported for human and rabbit Clq.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91570      PMCID: PMC1457737     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS.

Authors:  D A YPHANTIS
Journal:  Biochemistry       Date:  1964-03       Impact factor: 3.162

3.  Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis.

Authors:  H J MULLER-EBERHARD; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

4.  Detection of IgG aggregates or immune complexes using solid-phase C1q and protein A-rich Staphylococcus aureus as an indicator system.

Authors:  C Farrell; H Sogaard; S E Svehag
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

5.  Chemical analysis and electron microscopy studies of human C1q prepared by different methods.

Authors:  H R Knobel; W Villiger; H Isliker
Journal:  Eur J Immunol       Date:  1975-01       Impact factor: 5.532

6.  Structural studies on human Clq: non-covalent and covalent subunits.

Authors:  K Yonemasu; R M Stroud
Journal:  Immunochemistry       Date:  1972-05

7.  Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.

Authors:  V Agnello; R J Winchester; H G Kunkel
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

8.  C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.

Authors:  A T Sobel; V A Bokisch; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

9.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

10.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  2 in total

1.  Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.

Authors:  T L McDonald
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

2.  Purification and characterization of subcomponent C1q of the first component of mouse complement.

Authors:  K Yonemasu; T Sasaki
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.